# Rivet PVS Therapy in Group 2 PH-HFpEF Canada

> **NCT05332873** · NA · WITHDRAWN · sponsor: **NXT Biomedical**

## Conditions studied

- Heart Failure
- Pulmonary Hypertension

## Interventions

- **DEVICE:** Rivet Shunt

## Key facts

- **NCT ID:** NCT05332873
- **Lead sponsor:** NXT Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10
- **Primary completion:** 2024-05
- **Final completion:** 2025-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Commercial decision
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332873, "Rivet PVS Therapy in Group 2 PH-HFpEF Canada". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05332873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*